Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 112 M98 M95 M89 M139 M96 M 419 M Research & development —————— — Operating income 2 B1.83 B1.17 B1.22 B1.75 B1.9 B 6.04 B Non-Operating Income, Total 67 M60 M77 M215 M67 M53 M 412 M Interest expense, net of interest capitalized 245 M243 M237 M235 M240 M250 M 962 M Non-Operating Income, excl. Interest Expenses -178 M-183 M-160 M-20 M-173 M-197 M -550 M Unusual income/expense —————— — Pretax income 1.83 B1.65 B1.01 B1.06 B1.58 B1.7 B 5.35 B Equity in earnings —————— — Taxes 415 M415 M253 M222 M395 M411 M 1.28 B Non-controlling/minority interest 31 M20 M10 M13 M40 M25 M 88 M After tax other income/expense —————— — Net income before discontinued operations 1.38 B1.21 B747 M821 M1.15 B1.27 B 3.98 B Discontinued operations —————— — Net income 1.38 B1.21 B747 M821 M1.15 B1.27 B 3.98 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.38 B1.21 B747 M821 M1.15 B1.27 B 3.98 B Basic earnings per share (Basic EPS) 2.812.461.521.692.372.64 8.22 Diluted earnings per share (Diluted EPS) 2.792.451.511.682.362.63 8.18 Average basic shares outstanding 492 M492 M491 M491 M484 M480 M — Diluted shares outstanding 495 M495 M494 M494 M486 M482 M — EBITDA 2.09 B1.92 B1.26 B1.31 B1.84 B1.99 B 6.4 B EBIT 2 B1.83 B1.17 B1.22 B1.75 B1.9 B 6.04 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 88 M91 M91 M91 M89 M90 M 361 M